Literature DB >> 19915514

Inhaled nitric oxide decreases leukocyte trafficking in the neonatal mouse lung during exposure to >95% oxygen.

Melissa J Rose1, Michael R Stenger, Mandar S Joshi, Stephen E Welty, John Anthony Bauer, Leif D Nelin.   

Abstract

Chronic lung injury in the neonate is termed bronchopulmonary dysplasia (BPD). These patients generally require supplemental oxygen therapy, and hyperoxia has been implicated in the pathogenesis of BPD. The concomitant use of oxygen and inhaled NO (iNO) may result in the generation of reactive nitrogen species or may have an anti-inflammatory effect in the neonatal lung. We tested the hypothesis that exposure to >95% O2 in neonatal mice would increase trafficking of leukocytes into the lung and that the addition of iNO to >95% O2 would decrease this leukocyte trafficking. Hyperoxia resulted in fewer alveoli, increased presence of neutrophils and macrophages, and decreased number of mast cells within the lung parenchyma. Adding iNO to hyperoxia prevented the hyperoxia-induced changes and resulted in the numbers of alveoli, neutrophils, macrophages, and mast cells approximating those found in controls (room air exposure). Intercellular adhesion molecule (ICAM) and monocyte chemotactic protein-1 (MCP-1), two factors responsible for leukocyte recruitment, were up-regulated by hyperoxic exposure, but the addition of iNO to the hyperoxic exposure prevented the hyperoxia-induced up-regulation of ICAM and MCP-1. These data demonstrate that iNO alters the hyperoxia-induced recruitment of leukocytes into the lung.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19915514      PMCID: PMC2829761          DOI: 10.1203/PDR.0b013e3181ca0d93

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  25 in total

1.  Anti-neutrophil chemokine preserves alveolar development in hyperoxia-exposed newborn rats.

Authors:  R L Auten; S N Mason; D T Tanaka; K Welty-Wolf; M H Whorton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-08       Impact factor: 5.464

2.  Blocking neutrophil influx reduces DNA damage in hyperoxia-exposed newborn rat lung.

Authors:  Richard L Auten; Mary H Whorton; S Nicholas Mason
Journal:  Am J Respir Cell Mol Biol       Date:  2002-04       Impact factor: 6.914

3.  Lung lavage of newborns with respiratory distress syndrome. Prolonged neutrophil influx is associated with bronchopulmonary dysplasia.

Authors:  B E Ogden; S Murphy; G C Saunders; J D Johnson
Journal:  Chest       Date:  1983-05       Impact factor: 9.410

4.  Inhaled nitric oxide attenuates acute lung injury via inhibition of nuclear factor-kappa B and inflammation.

Authors:  Jihee Lee Kang; Wann Park; In Soon Pack; Hui Su Lee; Mi Jung Kim; Chae-Man Lim; Younsuck Koh
Journal:  J Appl Physiol (1985)       Date:  2002-02

Review 5.  Nitric oxide in the lung: therapeutic and cellular mechanisms of action.

Authors:  B Weinberger; D E Heck; D L Laskin; J D Laskin
Journal:  Pharmacol Ther       Date:  1999-12       Impact factor: 12.310

6.  Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group.

Authors:  R H Clark; T J Kueser; M W Walker; W M Southgate; J L Huckaby; J A Perez; B J Roy; M Keszler; J P Kinsella
Journal:  N Engl J Med       Date:  2000-02-17       Impact factor: 91.245

7.  Antimacrophage chemokine treatment prevents neutrophil and macrophage influx in hyperoxia-exposed newborn rat lung.

Authors:  Michael A Vozzelli; S Nicholas Mason; Mary H Whorton; Richard L Auten
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-02-14       Impact factor: 5.464

8.  Effect of endogenous nitric oxide on hyperoxia and tumor necrosis factor-alpha-induced leukosequestration and proinflammatory cytokine release in rat airways.

Authors:  Horng-Chyuan Lin; Chun-Hua Wang; Chih-Teng Yu; Kuo-Shiung Huang; Chien-Ying Liu; Chih-Wei Yang; Han-Pin Kuo
Journal:  Crit Care Med       Date:  2003-02       Impact factor: 7.598

9.  Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia.

Authors:  T A Merritt; C G Cochrane; K Holcomb; B Bohl; M Hallman; D Strayer; D K Edwards; L Gluck
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

10.  Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor.

Authors:  Jen-Ruey Tang; Neil E Markham; Yuh-Jyh Lin; Ivan F McMurtry; Anne Maxey; John P Kinsella; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-04-02       Impact factor: 5.464

View more
  9 in total

1.  Endotoxin inhalation alters lung development in neonatal mice.

Authors:  Katarina Kulhankova; Caroline L S George; Joel N Kline; Melissa Darling; Peter S Thorne
Journal:  Am J Ind Med       Date:  2012-05-10       Impact factor: 2.214

2.  L-citrulline supplementation reverses the impaired airway relaxation in neonatal rats exposed to hyperoxia.

Authors:  Ramadan B Sopi; Syed I A Zaidi; Mitko Mladenov; Hazbije Sahiti; Zahide Istrefi; Icko Gjorgoski; Azem Lajçi; Muharrem Jakupaj
Journal:  Respir Res       Date:  2012-08-07

3.  Synergistic protection against hyperoxia-induced lung injury by neutrophils blockade and EC-SOD overexpression.

Authors:  Jae H Min; Champa N Codipilly; Sonya Nasim; Edmund J Miller; Mohamed N Ahmed
Journal:  Respir Res       Date:  2012-07-20

4.  Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling.

Authors:  Tereza Cindrova-Davies; Deborah A Sanders; Graham J Burton; D Stephen Charnock-Jones
Journal:  Cardiovasc Res       Date:  2010-12-07       Impact factor: 10.787

Review 5.  Bronchopulmonary dysplasia early changes leading to long-term consequences.

Authors:  Anne Hilgendorff; Michael A O'Reilly
Journal:  Front Med (Lausanne)       Date:  2015-02-12

6.  Prevention of hyperoxia-induced bronchial hyperreactivity by sildenafil and vasoactive intestinal peptide: impact of preserved lung function and structure.

Authors:  Dorottya Czövek; Ferenc Peták; Yves Donati; Xavier Belin; Jean-Claude Pache; Constance Barazzone Argiroffo; Walid Habre
Journal:  Respir Res       Date:  2014-08-13

Review 7.  Nitric oxide and hyperoxic acute lung injury.

Authors:  Wen-Wu Liu; Cui-Hong Han; Pei-Xi Zhang; Juan Zheng; Kan Liu; Xue-Jun Sun
Journal:  Med Gas Res       Date:  2016-07-11

8.  Inflammatory Mediators in Tracheal Aspirates of Preterm Infants Participating in a Randomized Trial of Inhaled Nitric Oxide.

Authors:  Mandy Laube; Elena Amann; Ulrike Uhlig; Yang Yang; Hans W Fuchs; Michael Zemlin; Jean-Christophe Mercier; Rolf F Maier; Helmut D Hummler; Stefan Uhlig; Ulrich H Thome
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

Review 9.  Perinatal Inflammation: Could Partial Blocking of Cell Adhesion Molecule Function Be a Solution?

Authors:  Nikolaos Vrachnis; Dimitrios Zygouris; Dionysios Vrachnis; Nikolaos Roussos; Nikolaos Loukas; Nikolaos Antonakopoulos; Georgios Paltoglou; Stavroula Barbounaki; Georgios Valsamakis; Zoi Iliodromiti
Journal:  Children (Basel)       Date:  2021-05-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.